| Literature DB >> 12185665 |
Sara H Windahl1, Göran Andersson, Jan-Ake Gustafsson.
Abstract
Since the discovery that estrogen receptors (ERs) are present in bone cells, there has been intense research into the action of estrogen in bone. During the past decade, humans with disturbed estrogen signaling, either as a result of ER alpha or aromatase deficiency, have been reported. Furthermore, mouse models have been established with a deficiency of ER alpha, ER beta or both, in addition to deficiency of aromatase. This review focuses on data accumulated during the past three years from studies of knockout mice with impaired estrogen signaling resulting from ER or aromatase deficiency.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12185665 DOI: 10.1016/s1043-2760(02)00594-5
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN: 1043-2760 Impact factor: 12.015